•
Publications & Policy•
Publications•
Response to the European Commission Consultation on the EU life sciences strategy
Positions & consultation responses
Invest Europe’s response to the European Commission’s initiative to strengthen the biotech and life sciences ecosystem outlines key priorities in addressing regulatory barriers in medtech, unlocking early-stage investment, aligning public and private capital, and reducing fragmentation across EU markets, while broadening access to capital from all sources.
Response to European Commission Call for Evidence on EU Regulatory Framework for Financial Services
Positions & consultation responses
31 Jan 2016
EVCA-PAE Response to Green Paper on Capital Markets Union
Positions & consultation responses
13 May 2015
EC Green Paper on Capital Markets Union
Positions & consultation responses
18 Feb 2015
Response to the European Commission Consultation on the Rescue and Restructuring Guidelines
Positions & consultation responses
13 Nov 2025
Position paper on the next EU Budget
Positions & consultation responses
30 Oct 2025
Response to the European Commission Consultation on the 28th regime
Positions & consultation responses
29 Sep 2025
Response to the European Commission Consultation on the General Block Exemption Regulation (GBER)
Positions & consultation responses
29 Sep 2025
InvestEU Interim Evaluation Consultation Response
Positions & consultation responses
10 May 2023
Letter on state aid issues related to SME Definition
Positions & consultation responses
28 Apr 2020
MEMBER ONLY
EVCA Corporate Venturing European Activity Report 2002
Positions & consultation responses
01 Oct 2003
Position on the Scope of the Leaked 28th Regime Corporate Legal Framework (EU Inc.)
Positions & consultation responses
17 Mar 2026
Position Paper on Biotech & Healthcare
Positions & consultation responses
03 Nov 2025
Response to the European Commission Consultation on the European Innovation Act (EIA)
Positions & consultation responses
29 Sep 2025
Response to the European Commission Call for Evidence on the European Biotech Act
Positions & consultation responses
06 Jun 2025
Position paper on EU response to the US Inflation Reduction Act
Positions & consultation responses
16 Mar 2023
Response to the Commission’s targeted survey on simplifying the General Block Exemption Regulation (GBER)
Positions & consultation responses
02 Jul 2026
Position on the draft 2027-2034 General Block Exemption Regulation (GBER)
Positions & consultation responses
17 Apr 2026
Position on the European Biotech Act I
Positions & consultation responses
29 Apr 2026